Daniel McGahn
Chief Executive Officer chez AMERICAN SUPERCONDUCTOR CORPORATION
Fortune : 15 M $ au 31/03/2024
Profil
Daniel Patrick McGahn is currently the Chairman, President & Chief Executive Officer at American Superconductor Corp.
He previously served as a Director at BioDE Ventures Ltd.
and as an Independent Director at Exro Technologies, Inc. from 2017 to 2021.
McGahn also held the position of Chief Marketing Officer & Executive Vice President at Konarka Technologies, Inc. from 2003 to 2006.
Additionally, he served as the Chief Operating Officer & General Manager at Hyperion Catalysis International, Inc. McGahn obtained his undergraduate and graduate degrees from the Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/06/2023 | 1 088 672 ( 3,01% ) | 15 M $ | 31/03/2024 |
Postes actifs de Daniel McGahn
| Sociétés | Poste | Début |
|---|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Chief Executive Officer | 16/06/2011 |
Anciens postes connus de Daniel McGahn
| Sociétés | Poste | Fin |
|---|---|---|
| EXRO TECHNOLOGIES INC. | Director/Board Member | 19/08/2021 |
Konarka Technologies, Inc.
 Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Sales & Marketing | 01/01/2006 |
BioDE Ventures Ltd.
 BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Director/Board Member | - |
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Chief Operating Officer | - |
Formation de Daniel McGahn
| Massachusetts Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Producer Manufacturing |
| EXRO TECHNOLOGIES INC. | Producer Manufacturing |
| Entreprise privées | 3 |
|---|---|
Konarka Technologies, Inc.
Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Electronic Technology |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Producer Manufacturing |
BioDE Ventures Ltd.
BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Health Technology |
